InsiderTradesSIGMA

PicksTOP Companies Executives Performance Blog Topics

InsidersTradesSigma

InsiderTradesSIGMA

Multi-market insider intelligence. Official public filings, re-aggregated and scored. Private beta.

FRUSDEGBCHCAITESNLBENOSEFIDKAUATIEBRINJP+ 8 markets

Recommendations
Companies
Insiders
Performance
Backtest
Compare

Methodology
How it works
Glossary
API docs
Status
Blog

Sign in
Create account
Portfolio
API keys
Alerts
Upgrade

Privacy
Terms
Cookies
Contact
About

Built in Paris. Public sources across 28 markets: AMF France, SEC EDGAR Form 4 US, BaFin Germany, SIX SER Switzerland, RNS United Kingdom, SEDI Canada, Consob Italy, CNMV Spain, AFM Netherlands, FSMA Belgium, Oslo Bors Norway, Nasdaq Helsinki, Nasdaq Copenhagen, ASX Australia, FMA Austria, CVM Brazil, HKEX Hong Kong, BSE-Sofia Bulgaria, Tadawul Saudi Arabia, DART South Korea, EDINET Japan, SSE and SZSE China, SEBI India, KNF Poland, PSE Philippines, NZX New Zealand, JSE South Africa. Prices + fundamentals via Yahoo Finance, STOXX 600 sector ETFs (iShares Xetra). Stack: Next.js 16, Prisma, Vercel. Live out-of-sample tracker since 2026-05-16. Methodology audits: /methodologie and /docs/method-review/.

Sources: official public filings under MAR Art.19 (EU and EEA), SEC Section 16 / Form 4 (US), Art.56 SESTA (CH, SIX SER), NI 55-104 / SEDI (CA), Corporations Act s205G (AU) and equivalent regimes. Signals on this site are for educational use only and do not constitute investment advice within the meaning of MiFID II / SEC Reg-IA. Past performance does not guarantee future results. Swiss SIX SER filings are anonymised by law (role only, no name).

Theme: dark (range regime detected on CAC40 90d · as of 2026-05-22)

© 2026 Insiders TradesΣ·Private beta·Hosted on Vercel

All systems operational

InsidersTradesSigma

立方制药 (003020.SZ) — directors' dealings · AMF · 11 reports

← Companies ★ Sign in to follow

立方制药: directors' dealings · France · AMF

SZSE:003020FRFR·AMFMcap 4.9Bn€

Explore the full insider trade history of 立方制药, a listed equity based in France. Shares are listed on FR FR, under the supervision of AMF. Market capitalisation: €4.9bn. The latest transaction was reported on 21 June 2023 — Sale. Among the most active insiders: 汪琴. All data is openly available.

11

Insider Decl.

0

Thresholds

·

0 ops.

Buy Volume

·

11 ops.

Sell Volume

Financial data

FY ended December 2025 · cache

21.21 €

Income statement

Revenue1.55 Bn€

Gross profit1.00 Bn€65% margin

Net income165.2 M€10.6% margin

Balance sheet & cash

Market cap4.92 Bn€

Total debt63.9 M€

Free Cash Flow94.4 M€

Last declaration on 21 June 2023

All Executives11 Thresholds Prospectus Other

Declarations11 total

Executives●Sale7SZSE

汪

汪琴监事

4,000 shares

A股XSHE

SZSE:173000006680026460·21 Jun 2023

Executives●Sale7SZSE

汪

汪琴监事

4,000 shares

A股XSHE

SZSE:173000006672223800·20 Jun 2023

Executives●Sale7SZSE

汪

汪琴监事

3,000 shares

A股XSHE

SZSE:173000006669480220·19 Jun 2023

Executives●Sale7SZSE

汪

汪琴监事

5,000 shares

A股XSHE

SZSE:173000006666953950·16 Jun 2023

Executives●Sale7SZSE

汪

汪琴监事

2,000 shares

A股XSHE

SZSE:173000006663043170·15 Jun 2023

Executives●Sale7SZSE

汪

汪琴监事

5,000 shares

A股XSHE

SZSE:173000006660074430·14 Jun 2023

Executives●Sale7SZSE

汪

汪琴监事

12,000 shares

A股XSHE

SZSE:173000006657349250·13 Jun 2023

Executives●Sale7SZSE

王

王清董事,高管

10,000 shares

A股XSHE

SZSE:173000006314948540·24 Feb 2023

Executives●Sale7SZSE

王

王清董事,高管

20,000 shares

A股XSHE

SZSE:173000006064224900·21 Nov 2022

Executives●Sale11SZSE

许

许学余高管

7,000 shares

A股XSHE

SZSE:173000005965869500·20 Oct 2022

Executives●Sale11SZSE

许

许学余高管

28,000 shares

A股XSHE

SZSE:173000005962872960·19 Oct 2022

11 of 11 declarations